Metronomic doxifluridine chemotherapy combined with the anti-angiogenic agent TNP-470 inhibits the growth of human uterine carcinosarcoma xenografts

  • Yasuko Naganuma, Batsuren Choijamts, Kyoko Shirota, Kyoko Nakajima, Shigenori Ogata, Shingo Miyamoto, Tatsuhiko Kawarabayashi, Makoto Emoto
  • Cancer Science, July 2011, Wiley
  • DOI: 10.1111/j.1349-7006.2011.01998.x

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1111/j.1349-7006.2011.01998.x

In partnership with:

Link to Wiley showcase